5-Bromo-2-benzoxazolinone
CAS : 14733-73-4
Ref. 3D-FB12605
1g | Arrêté | ||
2g | Arrêté | ||
5g | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- 2(3H)-Benzoxazolone, 5-bromo-
- 2-Benzoxazolinone, 5-bromo-
- 2-Benzoxazolol, 5-bromo-
- 5-Bromo-2(3H)-benzoxazolone
- 5-Bromo-2-Benzoxazolinon
- 5-Bromo-2-benzoxazolone
- 5-Bromo-3H-benzoxazol-2-one
- 5-Bromobenzo[d]oxazol-2(3H)-one
- 5-bromo-1,3-benzoxazol-2(3H)-one
5-Bromo-2-benzoxazolinone is a drug that has been synthesised for use in clinical trials. It has shown to have affinity for the σ1 receptor, which is involved in the nervous system and depression. 5-Bromo-2-benzoxazolinone also has affinity for neuroblastoma cells, which can be used to treat cancer. 5-Bromo-2-benzoxazolinone is also an antagonist for the σ1 receptor, which may lead to psychosis or Parkinson's disease. This compound also has a high affinity for the ρ1 receptor, which is found in the brain and plays a role in depression and anxiety. 5-Bromo-2-benzoxazolinone is heterocyclic with an oxygen atom at its centre.